These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35833114)

  • 1. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma.
    Chen M; Wang X; Wang W; Gui X; Li Z
    Front Immunol; 2022; 13():829057. PubMed ID: 35833114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of a prognostic model for stemness-related genes in lung adenocarcinoma.
    Zhang H; Cao C; Xiong H
    Transl Cancer Res; 2024 Mar; 13(3):1351-1366. PubMed ID: 38617509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers.
    Zhang Y; Tseng JT; Lien IC; Li F; Wu W; Li H
    Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis.
    Zhao M; Chen Z; Zheng Y; Liang J; Hu Z; Bian Y; Jiang T; Li M; Zhan C; Feng M; Wang Q
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1463-1472. PubMed ID: 32221746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cancer stemness and M2 macrophage-associated biomarkers in lung adenocarcinoma.
    Wang X; Luo X; Wang Z; Wang Y; Zhao J; Bian L
    Heliyon; 2023 Sep; 9(9):e19114. PubMed ID: 37662825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
    Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
    Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. scRNA-seq revealed high stemness epithelial malignant cell clusters and prognostic models of lung adenocarcinoma.
    Lin G; Gao Z; Wu S; Zheng J; Guo X; Zheng X; Chen R
    Sci Rep; 2024 Feb; 14(1):3709. PubMed ID: 38355636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Bioinformatics Analysis Identifies a New Stemness Index-Related Survival Model for Prognostic Prediction in Lung Adenocarcinoma.
    Hou S; Xu H; Liu S; Yang B; Li L; Zhao H; Jiang C
    Front Genet; 2022; 13():860268. PubMed ID: 35464867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis.
    Han P; Yang H; Li X; Wu J; Wang P; Liu D; Xiao G; Sun X; Ren H
    Oncol Res; 2021 Sep; 28(7):715-729. PubMed ID: 33106209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer.
    Zhao X; Lin J
    Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a 5-Gene Signature to Evaluate Lung Adenocarcinoma Prognosis Based on the Features of Cancer Stem Cells.
    Wan R; Liao H; Liu J; Zhou L; Yin Y; Mu T; Wei J
    Biomed Res Int; 2022; 2022():4404406. PubMed ID: 35480140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
    Xu Q; Xu H; Chen S; Huang W
    Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
    Li F; Ge D; Sun SL
    BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Tumor Stemness Indice mRNAsi can Act as Molecular Typing Tool for Lung Adenocarcinoma.
    Yi Y; Liu X; Gao H; Qin S; Xu J; Ma F; Guan M
    Biochem Genet; 2023 Dec; 61(6):2401-2424. PubMed ID: 37100923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma.
    Huang XY; Qin WT; Su QS; Qiu CC; Liu RC; Xie SS; Hu Y; Zhu SY
    Biomed Res Int; 2021; 2021():6669570. PubMed ID: 34671679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a pathomics model for predicting mRNAsi in lung adenocarcinoma and exploration of biological mechanism.
    Chen R; Liu Y; Xie J
    Heliyon; 2024 Sep; 10(17):e37100. PubMed ID: 39286147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a prognostic model for lung adenocarcinoma polarity-related genes and analysis of immune landscape.
    Xu H; Du W; Jing X; Xie J; Li P
    Biotechnol Appl Biochem; 2024 Aug; 71(4):817-834. PubMed ID: 38475658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative stemness characteristics associated with prognosis and the immune microenvironment in lung adenocarcinoma.
    Wang H; Wang Y; Luo W; Zhang X; Cao R; Yang Z; Duan J; Wang K
    BMC Pulm Med; 2022 Dec; 22(1):463. PubMed ID: 36471379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape.
    Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X
    Front Oncol; 2023; 13():1199608. PubMed ID: 37409245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.